Ratings OMRON Corporation OTC Markets

Equities

OMRNY

US6821513032

Market Closed - OTC Markets 01:19:36 25/05/2024 am IST 5-day change 1st Jan Change
34.34 USD +1.48% Intraday chart for OMRON Corporation -1.04% -26.12%

Summary

  • From a short-term investment perspective, the company presents a deteriorated fundamental situation

Strengths

  • Historically, the company has been releasing figures that are above expectations.

Weaknesses

  • According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
  • The potential for earnings per share (EPS) growth in the coming years appears limited according to current analyst estimates.
  • With an expected P/E ratio at 147.56 and 73.77 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
  • The valuation of the company is particularly high given the cash flows generated by its activity.
  • For the last four months, the sales outlook for the coming years has been revised downwards. No recovery of the group's activities is yet foreseen.
  • For the past year, analysts have significantly revised downwards their profit estimates.
  • For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
  • The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
  • The overall consensus opinion of analysts has deteriorated sharply over the past four months.
  • Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.

Ratings chart - Surperformance

Sector: Electrical Components & Equipment

1st Jan change Capi. Investor Rating ESG Refinitiv
-26.12% 6.69B -
+4.34% 151B
A
+31.04% 145B
B+
+41.55% 136B
B+
+16.53% 64.88B
A-
+5.32% 40.2B
B
+121.05% 39.74B
C
+3.87% 31.24B
B
-14.91% 30.12B
B
+10.95% 29.62B
A-
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes